Ads
related to: cancer cell impact factor
Search results
... for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer...
FOX 4 Kansas City· 6 days agoThe data, which mark the first promising clinical results for a CDK2 inhibitor in combination with an approved CDK4/6 inhibitor, will be presented at the 2024 American Society of Clinical Oncology ...
Earnings call: Nanobiotix reports Q1 2024 results, advances with NBTXR3
Investing.com· 7 days agoSignificant strides were made in their collaboration with Janssen on the NBTXR3 development plan,...
Fathers' exposure to "harmful" forever chemicals may impact children
Newsweek· 7 days agoExposure to "forever chemicals" in male mice may impact the health of their future children,...
Researchers decipher mechanisms of liver regeneration
Medical Xpress· 6 days agoThe researchers were able to demonstrate this first by performing single-cell analyses on many...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Digital Journal· 7 days agoFor more information about Moderna, please visit modernatx.com and connect with us...guarantees, and you should not place undue reliance on these forward-looking statements because they involve ...
Microplastics found in testicles and blood clots, sparking more health concerns: studies
NY Post· 6 days agoBeyond potentially harming fertility and being carcinogenic, microplastics may even raise someone’s...
Innovative Techniques Open New Avenues in Drug Dis | Newswise
Newswise· 7 days agoVolume 29, Issue 2 of SLAS Discovery features two review articles, six original research articles...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days agoIovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer ...
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual...
FOX 59 Indianapolis· 5 days agoMabwell (688062.SH), an innovation-driven biopharmaceutical company, announced the data and latest...
'Moving Forward': Battling Parkinson's, He's Rowing His Way to Paralympic Games
KLAX-TV· 6 days agoFor decades, Todd Vogt has been dedicated to the sport of rowing, believing he was in peak physical...